Ask a Patient® Health News: Drugs & Treatments

May 2025 Safety Update Part 2: Spravato Antidepressant, Clozapine, Ambrisentan, Korean Sunscreens, Children's Claritin, "Gas Station Heroin," Fluoride Tablets, Medication Tips

May 2025 Safety Update: Duloxetine Recall; New Warnings for Gabapentin, Lyrica, Doxycycline, Other Antibiotics; Animal Testing Changes; FDA Delays Continue; Medication Tips

Phase-out of Animal Studies Requirement for Investigational New Drug Applications

FDA Delays Some Updates; Product Warnings for Topical Hair Loss Treatment; Supplements with Hidden Ingredients; Counterfeit Ozempic

April 2025 Drug Safety: Lidocaine cream; new side effects for migraine drugs; antidepressants study; Pluvicto for prostate cancer; Imfinzi; Tymlos; vitamin B-12 quality; microplastics in teabags

March 2025 Drug Safety Part 2: New warnings for MRI contrast agents; Baqsimi, Belsomra, Furoscix, Iluvien ophthalmic, Metronidazole; Recalls of ADHD and acne meds; medication tips

March 2025 Drug Safety Updates Part 1: Cardiac Risk Warning Removed for Testosterone Meds; News for Bactrim, Lybalvi, Nplate, Prolensa, Remicade, TNKase

Drug and Device Approvals: Deep Brain Stimulation Therapy for PD; generic Xarelto; neffy nasal epinephrine spray; Odactra for dust mite allergies; Encelto for rare eye disease

February 2025 Part 3 Drug Safety News: Geodon; Paxlovid; Ozempic shortage ends; blood thinners and A-Fib; drug-induced high blood pressure; REMS news; podcast recommendation

February 2025 Drug Safety Part 2: FDA REMS news; Abilify; Isoniazid; Ongentys for Parkinson's; Osphena for menopause

February 2025 Drug Safety Updates Part 1: Enhertu, Omvoh, Ozempic expanded approvals and new warnings; MS drug's new boxed warning; glaucoma eye drops and corneal swelling; Xtandi choking risk; more

New Formulations for Popular Meds; Nicotine and Health Risks; Generic Facility Warned; Anti-Aging Emerging Therapies and Hype; More